Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients
- 1 August 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (2) , 747-753
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controlsAtherosclerosis, 1997
- Lipoperoxidation and Glutathione-Dependent Enzymes in Uremic Anemia of CAPD PatientsNephron, 1997
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Lipid-lowering therapy in patients with renal diseaseKidney International, 1995
- Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysisAmerican Journal of Kidney Diseases, 1995
- Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysisKidney International, 1994
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Trace Elements and Lipid Peroxidation Abnormalities in Patients with Chronic Renal FailureNephron, 1991
- Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodKidney International, 1985
- Quantitative measurement of the total, peroxyl radical‐trapping antioxidant capability of human blood plasma by controlled peroxidationFEBS Letters, 1985